An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice

Overview of attention for article published in Diabetologia, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 23 X posts from 16 X users, with an upper bound of 69,686 followers.

A novel dual-acting GIP/xenin hybrid peptide shows great promise for treatment of #type2diabetes @UlsterUniLHS https://t.co/1l6EESAOTY

RT @DiabetologiaJnl: A novel dual-acting GIP/xenin hybrid peptide shows great promise for treatment of #type2diabetes @UlsterUniLHS https:…

A novel dual-acting GIP/xenin hybrid peptide shows great promise for treatment of #type2diabetes @UlsterUniLHS https://t.co/1l6EESSpLw

A novel dual-acting GIP/xenin hybrid peptide shows great promise for treatment of #T2D https://t.co/IfUNO1FBRu …… https://t.co/02pSG5Xyxz https://t.co/tGjWMDGCaQ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.